Jump to top navigation | Jump to main navigation | Jump to content
Therapeutic Goods Administration logo

Australian Influenza Vaccine Committee

25 November 2009

AIVC recommendations for the composition of influenza vaccine for 2010

The Australian Influenza Vaccine Committee (AIVC) met on 2nd October 2009, and agreed to adopt the September WHO recommendations.

The Committee decided that the influenza vaccine components for the year 2010 season should contain the following:

  • A (H1N1): an A/California/7/2009 (H1N1) - like strain, 15 µg HA per dose
  • A (H3N2): an A/Perth/16/2009 (H3N2) - like strain, 15 µg HA per dose
  • B: a B/Brisbane/60/2008 - like strain, 15 µg HA per dose

The following viruses are recommended as suitable vaccine strains:

  • A/California/7/2009 (H1N1) (NYMC X-179A, NYMC X-181, NYMC X-181A, NIBRG-121, NIBRG-121xp)
  • A/Perth/16/2009 (H3N2)- like virus (NYMC X-183)
  • B/Brisbane/60/2008

The SRID reference antigens for A/California/7/2009 (H1N1) (X-179A) and (X-181) strains are available from TGA; reagents for NIBRG-121 and NIBRG-121xp reassortants and antisera suitable for use with all reassortants are available from NIBSC (UK).

The SRID reference antigen for A/Perth/16/2009 (H3N2)- like virus will be available from TGA (Australia) and NIBSC.

The SRID reference antigen and antisera for B/Brisbane/60/2008 are available from TGA and NIBSC.